Diagnostics Pipeline: More AI-Reliant Platforms Being Approved by the FDA
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article